Greenfield Savings Bank Has $891,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Greenfield Savings Bank trimmed its stake in shares of CVS Health Co. (NYSE:CVS) by 1.2% during the fourth quarter, HoldingsChannel reports. The fund owned 19,857 shares of the pharmacy operator’s stock after selling 243 shares during the period. Greenfield Savings Bank’s holdings in CVS Health were worth $891,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in CVS. Grandview Asset Management LLC bought a new position in CVS Health in the fourth quarter valued at $311,000. Marcum Wealth LLC grew its position in CVS Health by 17.2% in the fourth quarter. Marcum Wealth LLC now owns 8,723 shares of the pharmacy operator’s stock valued at $392,000 after purchasing an additional 1,283 shares in the last quarter. Persium Advisors LLC bought a new position in CVS Health in the fourth quarter valued at $323,000. Bridge Creek Capital Management LLC grew its position in CVS Health by 0.6% in the fourth quarter. Bridge Creek Capital Management LLC now owns 57,767 shares of the pharmacy operator’s stock valued at $2,593,000 after purchasing an additional 330 shares in the last quarter. Finally, Moody National Bank Trust Division grew its position in CVS Health by 3.8% in the fourth quarter. Moody National Bank Trust Division now owns 24,185 shares of the pharmacy operator’s stock valued at $1,086,000 after purchasing an additional 885 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CVS. Barclays decreased their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Royal Bank of Canada decreased their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. Finally, Piper Sandler decreased their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Trading Up 7.4 %

Shares of CVS Health stock opened at $51.54 on Tuesday. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a market cap of $64.86 billion, a price-to-earnings ratio of 13.08, a PEG ratio of 0.85 and a beta of 0.59. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company’s 50-day moving average price is $51.76 and its 200-day moving average price is $56.49.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm posted $2.21 earnings per share. On average, equities analysts expect that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 5.16%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.